|
1
|
Lyman GH, Giuliano AE, Somerfield MR,
Benson AB III, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS III,
Edge SB, Galper S, et al: American society of clinical oncology
guideline recommendations for sentinel lymph node biopsy in
early-stage breast cancer. J Clin Oncol. 23:7703–7720. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lyman GH, Temin S, Edge SB, Newman LA,
Turner RR, Weaver DL, Benson AB III, Bosserman LD, Burstein HJ,
Cody H III, et al: Sentinel lymph node biopsy for patients with
early-stage breast cancer: American Society of Clinical Oncology
clinical practice guideline update. J Clin Oncol. 32:1365–1383.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Veronesi U, Paganelli G, Viale G, Luini A,
Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti
G, et al: Sentinel-lymph-node biopsy as a staging procedure in
breast cancer: Update of a randomised controlled study. Lancet
Oncol. 7:983–990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krag DN, Anderson SJ, Julian TB, Brown AM,
Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier
TG, et al: Technical outcomes of sentinel-lymph-node resection and
conventional axillary-lymph-node dissection in patients with
clinically node-negative breast cancer: Results from the NSABP B-32
randomised phase III trial. Lancet Oncol. 8:881–888. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamaki Y: One-step nucleic acid
amplification assay (OSNA) for sentinel lymph node biopsy. Breast
Cancer. 22:230–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimazu K, Sato N, Ogiya A, Sota Y,
Yotsumoto D, Ishikawa T, Nakamura S, Kinoshita T, Tsuda H, Ohi Y,
et al: Intraoperative nomograms, based on one-step nucleic acid
amplification, for prediction of non-sentinel node metastasis and
four or more axillary node metastases in breast cancer patients
with sentinel node metastasis. Ann Surg Oncol. 25:2603–2611. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rubio IT, Espinosa-Bravo M, Rodrigo M,
Amparo Viguri Diaz M, Hardisson D, Sagasta A, Dueñas B and Peg V:
Nomogram including the total tumoral load in the sentinel nodes
assessed by one-step nucleic acid amplification as a new factor for
predicting nonsentinel lymph node metastasis in breast cancer
patients. Breast Cancer Res Treat. 147:371–380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Osako T, Iwase T, Ushijima M, Yonekura R,
Ohno S and Akiyama F: A new molecular-based lymph node staging
classification determines the prognosis of breast cancer patients.
Br J Cancer. 117:1470–1477. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsujimoto M, Nakabayashi K, Yoshidome K,
Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, et
al: One-step nucleic acid amplification for intraoperative
detection of lymph node metastasis in breast cancer patients. Clin
Cancer Res. 13:4807–4816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamamoto N, Nakayama T, Kajita M, Miyake
T, Iwamoto T, Kim SJ, Sakai A, Ishihara H, Tamaki Y and Noguchi S:
Detection of aberrant promoter methylation of GSTP1, RASSF1A and
RARβ2 in serum DNA of patients with breast cancer by a newly
established one-step methylation-specific PCR assay. Breast Cancer
Res Treat. 132:165–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW,
Kim JH, Kim IA, Jung N, Cho NY and Kang GH: Promoter CpG island
hypermethylation during breast cancer progression. Virchows Arch.
458:73–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okamoto A: Chemical approach toward
efficient DNA methylation analysis. Org Biomol Chem. 7:21–26. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grunau C, Clark SJ and Rosenthal A:
Bisulfite genomic sequencing: Systematic investigation of critical
experimental parameters. Nucleic Acids Res. 29:E65–E75. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Chen WD, Papadopoulos N, Goodman SN,
Bjerregaard NC, Laurberg S, Levin B, Juhl H, Arber N, Moinova H, et
al: Sensitive digital quantification of DNA methylation in clinical
samples. Nat Biotechnol. 27:858–863. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Z, Bai Y, Cheng Z, Liu F, Wang P, Yang
D, Li G, Jin Q, Mao H and Zhao J: Absolute quantification of DNA
methylation using microfluidic chip-based digital PCR. Biosens
Bioelectron. 96:339–344. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suehiro Y, Zhang Y, Hashimoto S, Takami T,
Higaki S, Shindo Y, Suzuki N, Hazama S, Oka M, Nagano H, et al:
Highly sensitive faecal DNA testing of TWIST1 methylation in
combination with faecal immunochemical test for haemoglobin is a
promising marker for detection of colorectal neoplasia. Ann Clin
Biochem. 55:59–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suehiro Y, Hashimoto S, Higaki S, Fujii I,
Suzuki C, Hoshida T, Matsumoto T, Yamaoka Y, Takami T, Sakaida I
and Yamasaki T: Blood free-circulating DNA testing by highly
sensitive methylation assay to diagnose colorectal neoplasias.
Oncotarget. 9:16974–16987. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kristiansen S, Nielsen D and Sölétormos G:
Detection and monitoring of hypermethylated RASSF1A in serum from
patients with metastatic breast cancer. Clin Epigenetics. 8:352016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi H, Kagara N, Tanei T, Naoi Y,
Shimoda M, Shimomura A, Shimazu K, Kim SJ and Noguchi S:
Correlation of methylated circulating tumor DNA with response to
neoadjuvant chemotherapy in breast cancer patients. Clin Breast
Cancer. 17:61–69.e3. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oshiro C, Kagara N, Naoi Y, Shimoda M,
Shimomura A, Maruyama N, Shimazu K, Kim SJ and Noguchi S: PIK3CA
mutations in serum DNA are predictive of recurrence in primary
breast cancer patients. Breast Cancer Res Treat. 150:299–307. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morimoto K, Kim SJ, Tanei T, Shimazu K,
Tanji Y, Taguchi T, Tamaki Y, Terada N and Noguchi S: Stem cell
marker aldehyde dehydrogenase 1-positive breast cancers are
characterized by negative estrogen receptor, positive human
epidermal growth factor receptor type 2 and high Ki67 expression.
Cancer Sci. 100:1062–1068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miyamura Y, Kagara N, Miyake T, Tanei T,
Naoi Y, Shimoda M, Shimazu K, Kim SJ and Noguchi S: Drainage of
tumor-derived DNA into sentinel lymph nodes in breast cancer
patients. Pathol Oncol Res. Feb 25–2019.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jahr S, Hentze H, Englisch S, Hardt D,
Fackelmayer FO, Hesch RD and Knippers R: DNA fragments in the blood
plasma of cancer patients: Quantitations and evidence for their
origin from apoptotic and necrotic cells. Cancer Res. 61:1659–1665.
2001.PubMed/NCBI
|
|
24
|
Heitzer E, Ulz P and Geigl JB: Circulating
tumor DNA as a liquid biopsy for cancer. Clin Chem. 61:112–123.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Broderick DK, Di C, Parrett TJ, Samuels
YR, Cummins JM, McLendon RE, Fults DW, Velculescu VE, Bigner DD and
Yan H: Mutations of PIK3CA in anaplastic oligodendrogliomas,
high-grade astrocytomas and medulloblastomas. Cancer Res.
64:5048–5050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cancer Genome Atlas Network, .
Comprehensive molecular portraits of human breast tumours. Nature.
490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pereira B, Chin SF, Rueda OM, Vollan HK,
Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ,
et al: The somatic mutation profiles of 2,433 breast cancers
refines their genomic and transcriptomic landscapes. Nat Commun.
7:114792016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Teramoto A, Shimazu K, Naoi Y, Shimomura
A, Shimoda M, Kagara N, Maruyama N, Kim SJ, Yoshidome K, Tsujimoto
M, et al: One-step nucleic acid amplification assay for
intraoperative prediction of non-sentinel lymph node metastasis in
breast cancer patients with sentinel lymph node metastasis. Breast.
23:579–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maitra A, Wistuba II, Washington C,
Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF and Minna JD:
High-resolution chromosome 3p allelotyping of breast carcinomas and
precursor lesions demonstrates frequent loss of heterozygosity and
a discontinuous pattern of allele loss. Am J Pathol. 159:119–130.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cornelisse CJ, van de Velde CJ, Caspers
RJ, Moolenaar AJ and Hermans J: DNA ploidy and survival in breast
cancer patients. Cytometry. 8:225–234. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kimmig R, Wimberger P, Kapsner T and
Hillemanns P: Flow cytometric DNA analysis using cytokeratin
labeling for identification of tumor cells in carcinomas of the
breast and the female genital tract. Anal Cell Pathol. 22:165–178.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dayal JH, Sales MJ, Corver WE, Purdie CA,
Jordan LB, Quinlan PR, Baker L, ter Haar NT, Pratt NR and Thompson
AM: Multiparameter DNA content analysis identifies distinct groups
in primary breast cancer. Br J Cancer. 108:873–880. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Galimberti V, Cole BF, Viale G, Veronesi
P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli
M, et al: Axillary dissection versus no axillary dissection in
patients with breast cancer and sentinel-node micrometastases
(IBCSG 23-01): 10-year follow-up of a randomised, controlled phase
3 trial. Lancet Oncol. 19:1385–1393. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fujita N, Nakayama T, Yamamoto N, Kim SJ,
Shimazu K, Shimomura A, Maruyama N, Morimoto K, Tamaki Y and
Noguchi S: Methylated DNA and total DNA in serum detected by
one-step methylation-specific PCR is predictive of poor prognosis
for breast cancer patients. Oncology. 83:273–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chu PG and Weiss LM: Keratin expression in
human tissues and neoplasms. Histopathology. 40:403–439. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vilardell F, Novell A, Martin J, Santacana
M, Velasco A, Díez-Castro MJ, Cuevas D, Panadés MJ, González S
Llombart A, et al: Importance of assessing CK19 immunostaining in
core biopsies in patients subjected to sentinel node study by OSNA.
Virchows Arch. 460:569–575. 2012. View Article : Google Scholar : PubMed/NCBI
|
